Filing Details

Accession Number:
0001181431-11-018428
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-03-16 16:14:00
Reporting Period:
2011-01-18
Filing Date:
2011-03-16
Accepted Time:
2011-03-16 16:14:00
Original Submission Date:
2011-01-18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378586 Gautam Shah C/O Achillion Pharmaceuticals
300 George Street
New Haven CT 06511
Svp And Chief Compliance Ofc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-18 4,000 $1.60 7,125 No 4 M Direct
Common Stock Acquisiton 2011-01-18 2,000 $1.60 9,125 No 4 M Direct
Common Stock Acquisiton 2011-01-18 5,000 $1.05 14,125 No 4 M Direct
Common Stock Acquisiton 2011-01-18 3,312 $3.28 17,437 No 4 M Direct
Common Stock Disposition 2011-01-18 14,312 $4.86 3,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Footnotes
  1. These shares were unintentionally overstated on the reporting person's Form 4 filed on January 18, 2011.
  2. The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $4.74 to $5.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.